Cefepime
Back to searchMolecule Structure
Scientific Name
Cefepime
Description of the Drug
Cefepime is a fourth-generation cephalosporin antibiotic used in the treatment of infections caused by susceptible bacteria, such as pneumonia, urinary tract infections, and skin infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01413
http://www.drugbank.ca/drugs/DB01413
Brand Name(s)
Maxipime, Renapime
Company Owner(s)
Astral Steritech Pvt Ltd, Sagent Pharmaceuticals Inc, B Braun Medical Inc, Fosun Pharma Usa Inc, Hospira Inc, Samson Medical Technologies Llc, Baxter Healthcare Corp, Qilu Pharmaceutical Co Ltd, Acs Dobfar Spa
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2354204 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL65720 | ||
| PharmGKB | PA164754876 | ||
| Human Metabolome Database | HMDB0015483 | ||
| DrugBank | DB01413 | ||
| PubChem: Thomson Pharma | 14932491 | ||
| PubChem | 5479537 | ||
| EPA CompTox Dashboard | DTXSID70873208 | ||
| DrugCentral | 535 | ||
| Brenda | 951 | 232627 | |
| ChemicalBook | CB1737417 | ||
| Guide to Pharmacology | 10772 | ||
| GSRS | 1ea37786-4d7b-4457-8d77-f0ff52eb8f5d | ||
| rxnorm | CEFEPIME | CEFEPIME HYDROCHLORIDE | MAXIPIME |
| PubChem: Drugs of the Future | 12012932 | ||
| KEGG Ligand | C08111 | ||
| ChEBI | 478164 |
